Marimed Free Cash Flow (FCF) History (MRMD)
Marimed reported $6.5M in free cash flow for fiscal 2025, an increase of $11.7M from the previous fiscal year, with a free cash flow margin of 4.08%.
View full Marimed company overviewMarimed free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | $6.5M | $11.7M | — | +4.08% |
| 2024 | 2024-12-31 | −$5.2M | $7.0M | — | −3.28% |
| 2023 | 2023-12-31 | −$12.2M | −$7.4M | — | −8.22% |
| 2022 | 2022-12-31 | −$4.8M | −$22.8M | — | −3.60% |
| 2021 | 2021-12-31 | $18.0M | $19.3M | — | +14.80% |
| 2020 | 2020-12-31 | −$1.3M | $32.5M | — | −2.57% |
| 2019 | 2019-12-31 | −$33.8M | −$22.0M | — | −74.13% |
| 2018 | 2018-12-31 | −$11.8M | $7.4M | — | −99.83% |
| 2017 | 2017-12-31 | −$19.2M | −$15.6M | — | −316.60% |
| 2016 | 2016-12-31 | −$3.6M | −$3.1M | — | −99.94% |
| 2014 | 2014-12-31 | −$457,890 | — | — | −518.07% |
Marimed quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.9M | $1.9M | — | +4.58% |
| Q1 2026 | 2026-03-31 | $576,000 | −$451,000 | −43.91% | +1.46% |
| Q4 2025 | 2025-12-31 | $3.4M | $4.9M | — | +8.15% |
| Q3 2025 | 2025-09-30 | $2.1M | $3.9M | — | +5.19% |
| Q2 2025 | 2025-06-30 | −$12,000 | $1.8M | — | −0.03% |
| Q1 2025 | 2025-03-31 | $1.0M | $1.2M | — | +2.71% |
| Q4 2024 | 2024-12-31 | −$1.5M | $676,000 | — | −3.80% |
| Q3 2024 | 2024-09-30 | −$1.8M | −$3.7M | — | −4.34% |
| Q2 2024 | 2024-06-30 | −$1.8M | $2.7M | — | −4.41% |
| Q1 2024 | 2024-03-31 | −$158,000 | $7.4M | — | −0.42% |
| Q4 2023 | 2023-12-31 | −$2.1M | −$1.7M | — | −5.52% |
| Q3 2023 | 2023-09-30 | $1.9M | $723,000 | +59.56% | +4.99% |
| Q2 2023 | 2023-06-30 | −$4.5M | $5.6M | — | −12.21% |
| Q1 2023 | 2023-03-31 | −$7.6M | −$12.0M | — | −21.96% |
| Q4 2022 | 2022-12-31 | −$418,000 | −$4.8M | — | −1.17% |
| Q3 2022 | 2022-09-30 | $1.2M | −$2.8M | −69.52% | +3.58% |
| Q2 2022 | 2022-06-30 | −$10.1M | −$15.3M | — | −30.62% |
| Q1 2022 | 2022-03-31 | $4.5M | $24,000 | +0.54% | +14.31% |
| Q4 2021 | 2021-12-31 | $4.4M | $3.2M | +264.45% | +14.12% |
| Q3 2021 | 2021-09-30 | $4.0M | $4.3M | — | +11.99% |
| Q2 2021 | 2021-06-30 | $5.2M | $5.6M | — | +15.86% |
| Q1 2021 | 2021-03-31 | $4.5M | $6.2M | — | +18.06% |
| Q4 2020 | 2020-12-31 | $1.2M | $4.1M | — | +5.91% |
| Q3 2020 | 2020-09-30 | −$329,045 | $4.6M | — | −2.44% |
| Q2 2020 | 2020-06-30 | −$410,523 | $17.8M | — | −4.27% |
| Q1 2020 | 2020-03-31 | −$1.8M | $6.0M | — | −23.71% |
| Q4 2019 | 2019-12-31 | −$2.9M | $149,950 | — | −8.42% |
| Q3 2019 | 2019-09-30 | −$4.9M | −$1.6M | — | −116.96% |
| Q2 2019 | 2019-06-30 | −$18.2M | −$14.9M | — | −498.61% |
| Q1 2019 | 2019-03-31 | −$7.8M | −$5.6M | — | −220.79% |
| Q4 2018 | 2018-12-31 | −$3.0M | $7.3M | — | −88.16% |
| Q3 2018 | 2018-09-30 | −$3.3M | $1.8M | — | −98.03% |
| Q2 2018 | 2018-06-30 | −$3.3M | −$1.3M | — | −112.62% |
| Q1 2018 | 2018-03-31 | −$2.2M | −$494,366 | — | −104.02% |
| Q4 2017 | 2017-12-31 | −$10.3M | −$8.2M | — | −654.15% |
| Q3 2017 | 2017-09-30 | −$5.1M | — | — | −300.11% |
| Q2 2017 | 2017-06-30 | −$2.1M | — | — | −126.56% |
| Q1 2017 | 2017-03-31 | −$1.7M | — | — | −145.33% |
| Q3 2016 | 2016-09-30 | −$2.2M | — | — | −246.35% |
Marimed free cash flow growth trends
Over the last five reported fiscal years, free cash flow grew from −$1.3M to $6.5M, a net increase of $7.8M. Marimed's latest reported quarter, Q2 2026, generated $1.9M in free cash flow, an increase of $1.9M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Marimed filings at SEC.gov ↗